What Stedman Pharmaceuticals does

Stedman Pharmaceuticals Pvt. Ltd. is a privately held pharmaceutical company founded in 1991 and headquartered in Chennai, India, with a WHO-GMP approved manufacturing facility located approximately 40 km south of Chennai in the SIDCO Pharmaceutical Complex at Alathur, Thiruporur, Tamil Nadu. The facility houses automated production lines for oral solids, oral liquids, topical ointments/creams/gels, topical solutions, and topical powders, and co-locates a DSIR-approved R&D department that supports formulation development. The product portfolio covers more than a dozen therapeutic categories — analgesics, antibiotics, anti-gout, anti-obesity, antifibrinolytics, aminoacid and vitamin supplements, cardiovascular and antidiabetic drugs, gastrointestinal drugs, neurological drugs, phosphodiesterase inhibitors, respiratory drugs, and topical anti-infectives/analgesics/skin protectants — with specialized focus areas including aminoacid-based formulations (AMINORICH, Lysomin), topical antimicrobials (DREZ, FUNGINIL, MUPISURE), and oral Vitamin-D products (Jusdee line).

The company operates a multi-divisional structure: a domestic Indian Market distribution channel, an International Market export channel covering over 30 countries, a separate Stedman Wellness consumer division, a separate Stedman Diagnostics division, and an equal-partnership joint venture, Anabond Stedman Pharma Research (P) Ltd, manufacturing specialized dental materials. Revenue mechanics are undisclosed; the company does not publicly report pricing tiers, subscription models, or financial figures, and operates through field sales representatives supported by a Sales Force Automation system alongside domestic distributors and pharmacy channels. No venture funding, private equity backing, institutional investors, or public listing is disclosed, and the company appears to be founder/management-owned with no recent leadership changes, acquisitions, or funding events documented in available material.

Name

Stedman Pharmaceuticals

Legal name

Stedman Pharmaceuticals Pvt. Ltd.

Website

https://stedmanpharma.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Stedman Pharmaceuticals is a privately held Indian pharmaceutical manufacturer founded in 1991, headquartered in Chennai, producing generic formulations across 12+ therapeutic categories at a WHO-GMP facility, exporting to 30+ countries and operating wellness, diagnostics, and dental-materials divisions.

Ownership category

akta.pro rank

Product category

Pharmaceutical Formulations

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Pharmaceutical formulations
• Topical antimicrobials
• Amino acid supplements
• Vitamin D formulations
• Generic medicines

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Formulations - Indian Market: Manufacture and marketing of pharmaceutical formulations (oral solids, liquids, topicals) through domestic distribution across India. Products cover therapeutic categories including analgesics, antibiotics, cardiovascular, gastrointestinal, neurological, respiratory, and vitamin/mineral supplements.
2. Pharmaceutical Formulations - International Market: Export of pharmaceutical formulations to over 30 countries internationally. Product portfolio includes oral tablets/capsules, oral liquids/powders, and topical preparations marketed under Stedman brands globally.
3. Consumer Wellness Products (Stedman Wellness): Separate consumer wellness product division operating under the Stedman Wellness brand, covering over-the-counter and consumer health products.
4. Diagnostic Devices (Stedman Diagnostics): Separate diagnostic devices division operating under the Stedman Diagnostics brand.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Stedman Pharmaceuticals manufactures and markets branded pharmaceutical formulations (oral solids, oral liquids, topicals) from a WHO-GMP approved facility in Tamil Nadu for the Indian domestic market and exports to over 30 countries. The product portfolio spans analgesics, antibiotics, cardiovascular/diabetes drugs, gastro-intestinal drugs, neurology drugs, respiratory drugs, phosphodiesterase inhibitors, and topical antimicrobials, with specialized brands in aminoacid-based supplements (AMINORICH, Lysomin), Vitamin D (Jusdee), and antiseptic wound care (DREZ). The company also operates separate Wellness and Diagnostics divisions, plus a joint venture in dental materials.

Product overview

Stedman Pharmaceuticals is a pharmaceutical company founded in 1991, headquartered in Chennai, India, with a strong international presence in over 30 countries. The company operates as a multi-divisional enterprise offering pharmaceutical formulations alongside complementary consumer wellness and diagnostic product lines. Its core pharmaceutical portfolio is organized across the Indian Market and International Market divisions, covering oral solids (tablets and capsules), oral liquids (suspensions, syrups, and drops), topical formulations (ointments, creams, gels, powders, and solutions), and specialized amino acid-based formulations and vitamin D products. The product range spans therapeutic categories including analgesics/anti-inflammatory, antibacterial, antibiotics, anti-gout, anti-obesity, cardiovascular/diabetes drugs, gastro-intestinal drugs, neurology drugs, phosphodiesterase inhibitors (for erectile dysfunction and BPH), respiratory drugs, amino acid/vitamin supplements, mineral supplements, topical analgesics, topical anti-infectives, topical anti-fungals, topical skin protectants, topical steroids, antiseptic gargles, hand sanitisers, oral rehydration salts, and vaginal wash solutions. Beyond its pharmaceutical formulations business, Stedman operates three supplementary divisions: Stedman Wellness (consumer wellness products), Stedman Diagnostics (diagnostic devices), and holds an equal stake in the joint venture Anabond Stedman Pharma Research (P) Ltd for specialized dental materials.

Differentiator

Problem solved

Functional benefit

Brands

• Dygerm: Hand sanitizer product line
• STEDNAC
• AMINORICH
• Jusdee
• DREZ
• CONTUS
• Lysomin

Products and services

• STEDNAC Analgesic/Anti-inflammatory Line Branded analgesic and anti-inflammatory pharmaceutical formulations including STEDNAC Tablets (Aceclofenac 100 mg), STEDNAC-P (Aceclofenac + Paracetamol), STEDNAC Plus (Paracetamol), STEDNAC MR and STEDNAC TH (Thiocolchicoside), ODIL-20 (Piroxicam), VOLTINA (Diclofenac), IBUDOL (Ibuprofen 400/600/800 mg), PARAMELT (Paracetamol mouth-dissolving), and DE-SPAS (Dicyclomine + Paracetamol). Targets pain and inflammation management for prescribing physicians and patients.
• Antibiotic and Antibacterial Formulations Branded antibiotic and antibacterial formulations including LEQUIN 500 (Levofloxacin), TORZOLE 500 (Metronidazole), BACTEZOA (Ofloxacin + Ornidazole), DOXMAN (Doxycycline), AZINA 500 (Azithromycin), INDYCIN 300 (Clindamycin), plus suspensions OPTIMOL (Paracetamol), TORZOLE Suspension, and AZINA Forte Suspension (Azithromycin). For treatment of bacterial infections across multiple therapeutic indications.
• Cardiovascular and Diabetes Formulations Cardiovascular and antidiabetic formulations including STEDPRIL 10 (Enalapril), LIPIDOWN (Atorvastatin 10/20 mg), L-SART 50 (Losartan), NUMET (Metformin 500/850 mg), GLUBEN (Glibenclamide), HTNORM 50 and HTGARD 50 (Atenolol), AMDINE 5 (Amlodipine), and MEGASART 40 (Telmisartan). For management of hypertension, diabetes, and lipid disorders.
• Gastro-intestinal Formulations Gastro-intestinal pharmaceutical formulations including OMAPIN Forte (Omeprazole), RABEFLUX and RABEFLUX DSR (Rabeprazole + Domperidone), NEUTRAFLUX Chewable and Suspension (antacid with Simeticone), CAPANT (Pantoprazole), Antem-8 (Ondansetron), SICLOMIN Suspension (Dicyclomine + Simethicone), and Sucragel O Suspension (Sucralfate + Oxetacaine). For acid reflux, ulcers, and GI disorders.
• Neurology Formulations Neurology pharmaceutical formulations including NOOCETAM (Piracetam 400 mg), HEFUNAR (Flunarizine 5 mg), and NUREXEL 400 (Gabapentin). For neurological conditions including cognitive disorders, migraine prophylaxis, and neuropathic pain.
• Phosphodiesterase Inhibitor Formulations Phosphodiesterase inhibitor formulations including TARFIL (Tadalafil 5/10/20 mg) and VEREKTA (Sildenafil Citrate 25/50/100 mg). For treatment of erectile dysfunction and benign prostatic hyperplasia (BPH).
• CONTUS Respiratory Line Comprehensive respiratory product line including CONTUS Cough Tablets (Chlorphenamine + Phenylephrine + Dextromethorphan), CONTUS-650 (Paracetamol), CONTUS-ML (Montelukast + Levocetirizine), CONTUS Plus, CONTUS Paediatric Drops, CONTUS Paediatric Linctus, CONTUS Plus Paediatric Suspension, plus XPUTUM (Salbutamol + Ambroxol), XPUTUM LS (Levosalbutamol + Ambroxol + Guaiphenesin), Xputum Syrup (Terbutaline + Ambroxol), and INTAMOL (Salbutamol). For cough, cold, and respiratory conditions in adults and pediatric patients.
• AMINORICH Amino Acid Line Specialized amino acid-based formulations including AMINORICH Capsules (essential amino acids L-Isoleucine, L-Leucine, L-Valine, L-Lysine, L-Methionine, L-Threonine, L-Phenylalanine, L-Glutamine, L-Arginine plus vitamins and Zinc), AMINORICH Drops, AMINORICH Liquid, AMINORICH Granules, and Lysomin Capsules and Liquid. Targets negative nitrogen balance recovery from infections, injuries, and surgical outcomes. Includes ARGIRICH Granules (L-Arginine complex) as an amino acid supplement.
• Jusdee Vitamin D Line Oral Vitamin D3 formulations in multiple dosage forms and strengths including Jusdee 1000 Tablets, Jusdee 60K Chewable Tablets, JusDee 400 Drops, JusDee 400 Suspension, JusDee 800 Suspension, and JUSDEE 60K Granules. For Vitamin D supplementation across age groups and clinical needs.
• DREZ Topical Anti-infective Line Comprehensive DREZ antiseptic wound care and topical anti-infective product line including DREZ Ointment (Iodinated Povidone + Metronidazole), DREZ-V Gel (Miconazole + Metronidazole), DREZ Powder, DREZ Solution, DREZ Gargle, Drez Ready Gargle, and Drez Throat Spray. For wound care, topical infections, and antiseptic applications.
• Topical Analgesic Gels Topical analgesic gels including STEDNAC Gel (Aceclofenac + Linseed Oil + Methyl Salicylate + Menthol), CAPSITOP Gel (Capsaicin + Diclofenac + Menthol + Methyl Salicylate), CAPSIDEX Gel (Capsaicin + Methyl Salicylate), Versar Gel (Diclofenac), ORABENZ Gel (Benzocaine), and BENZONAC Gel (Diclofenac + Benzocaine). For localized pain relief.
• Topical Anti-fungal and Skin Protectant Line Topical anti-fungal and skin protectant products including FUNGINIL Cream (Clotrimazole), METZ Gel (Metronidazole), MUPISURE Ointment (Mupirocin), MICROGARD S Cream (Silver Sulphadiazine + Chlorhexidine + Metronidazole), Azole Cream (Clotrimazole), Hexum Gel (Chlorhexidine), NEODERM Ointment (Benzoic + Salicylic Acid), HYDRALAC Cream and Lotion (Ammonium Lactate), ZEEDERM Cream (Zinc Oxide), Calagold Lotion (Calamine + Zinc Oxide), BETCORT Ointment/Cream (Betamethasone), and K-Lice Lotion (Dimethicone). For skin infections, fungal conditions, and skin protection.
• Specialized Topical and Dental Formulations Specialized topical and dental products including DENTASEP Dental Gel (Metronidazole + Chlorhexidine), DREZ Gargle (Povidone-Iodine), Drez Ready Gargle, Drez Throat Spray, DREZ Powder, DREZ Solution, MICROBACT Powder (Miconazole + Chlorhexidine), CALAGOLD Lotion (Calamine), VYGENE Vaginal Wash (Lactic Acid + Lactoserum), and DYGERM Hand Sanitizer (Isopropyl Alcohol 70%). For dental, oral hygiene, antiseptic, and personal hygiene applications.
• Miscellaneous Therapeutic Formulations Other therapeutic category products including ZYRINOL 300 (Allopurinol for anti-gout), Trislim 120 (Orlistat for anti-obesity), Effinex 500 (Tranexamic Acid as antifibrinolytic), and ELYTE Powder (Oral Rehydration Salts). Also includes vitamin/mineral supplements STEDMAN M-Cal 250, M-CALZ Tablets and Suspension, VITAFIL-Z, VITAFIL C, VITAFIL Forte Drops and Syrup, ZINCA, YESCAL Tablets and Suspension, STEDFER, VERZ Syrup (Zinc Acetate), PRODIN Liquid (Iron Protein Succinylate), and LORAST Syrup (Loratadine). For anti-gout, weight management, antifibrinolytic therapy, oral rehydration, and nutritional supplementation.
• Stedman Wellness Division Separate consumer wellness product division covering over-the-counter and consumer health products under the Stedman Wellness brand, accessible at stedmanwellness.com. Forms part of Stedman's broader brand portfolio alongside pharmaceutical formulations.
• Stedman Diagnostics Division Separate diagnostic devices division serving clinical and point-of-care diagnostic needs, accessible at stedmandiagnostics.com. Forms part of Stedman's broader brand portfolio alongside pharmaceutical formulations.
• Anabond Stedman Pharma Research (P) Ltd (Joint Venture) Equal-partner joint venture company that manufactures specialized dental materials, operated as a separate legal entity from Stedman's core pharmaceutical business. Strategic diversification into specialized dental healthcare products.

Quantifiable outcome

• Presence in over 30 countries globally

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Anabond Stedman Pharma Research (P) LtdcoreOthersStedman Pharmaceuticals is an equal partner in a joint-venture company, Anabond Stedman Pharma Research (P) Ltd, which manufactures specialized dental materials. This joint venture represents a strategic diversification into specialized dental healthcare products.

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Cipla: Major Indian generic pharmaceutical manufacturer with comparable multi-therapeutic portfolio spanning respiratory, cardiovascular, anti-infectives, and dermatology, plus strong international export presence. Closest analogue to Stedman in business model and category breadth.
• Ajanta Pharma: Indian specialty generic pharma company with branded formulations in cardiology, dermatology, ophthalmology, and pain management, plus significant exports to Africa, Asia, and the US — similar branded-generic export profile.
• Unichem Laboratories: Indian pharma company focused on formulations in cardiology, neurology, gastroenterology, and dermatology with presence in US, UK, and emerging markets — comparable multi-therapeutic formulations business.
• Glenmark Pharmaceuticals: Indian pharmaceutical company with a broad generic-plus-specialty portfolio (dermatology, respiratory, oncology, cardiovascular) and meaningful export business to semi-regulated markets, similar to Stedman's positioning.
• Ipca Laboratories: Indian manufacturer of pharmaceutical formulations with strong presence in anti-infectives, analgesics, anti-malarials, and cardiovascular therapies, plus exports to global markets — comparable therapeutic mix and export orientation.
• Mankind Pharma: India-focused pharmaceutical company with a diversified portfolio across antibiotics, cardiovascular, gastrointestinal, dermatology, and consumer health — closely mirroring Stedman's domestic multi-therapeutic, sales-led model.
• Torrent Pharmaceuticals: Indian pharmaceutical company with diversified formulations across therapeutic areas (cardiology, diabetology, neurology, gastroenterology, gynecology) and international presence, comparable to Stedman's breadth and exports.
• Alembic Pharmaceuticals: Indian manufacturer of branded and generic formulations across anti-infectives, cardiology, dermatology, and respiratory with international business — closely comparable in therapeutic scope and export-led model.

Broad incumbents

• Cadila Healthcare (Zydus): Large diversified Indian pharmaceutical group spanning formulations, APIs, biosimilars, and consumer wellness, with substantial export business — a broader incumbent comparable in therapeutic and geographic breadth.

Regional players

• Emami: Indian consumer healthcare and OTC products company with brands spanning personal care, wellness, and over-the-counter health — comparable to Stedman's Stedman Wellness division and Dygerm sanitizer line on the consumer side.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/stedmanpharma
• LinkedInlinkedin.com/company/stedman-pharmaceuticals-private-limited

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stedman Pharmaceuticals